Individually different "weights" of quality of life assessment in patients with advanced nonsmall-cell lung cancer

Journal of Clinical Epidemiology

Volumn 56, Issue 8, 2003, Pages 744-751

  Morita, Satoshi ^a,j   Ohashi, Yasuo ^a   Kobayashi, Kunihiko ^b   Matsumoto, Taketoshi ^c   Eguchi, Kenji ^d   Shibuya, Masahiko ^e   Yamaji, Yasufumi ^f   Fukuoka, Masahiro ^g   Nagao, Keiichi ^h   Niitani, Hisanobu ⁱ  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^e NIPPON MEDICAL SCHOOL   (Japan)

^f Mitoyo General Hospital   (Japan)

^g KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h CHIBA UNIVERSITY   (Japan)

ⁱ Tokyo Cooperative Oncology Group   (Japan)

^j KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Chemotherapy; Nonsmall cell lung cancer; QOL ACD; Quality of life; Random coefficients model; Weights

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0041883655     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(03)00087-8     Document Type: Article

References (30)

1. Aaronson N.K., Bullinger M., Ahmedzai S. A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results Cancer Res. 111:1988;231-249.
2. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 85:1993;365-376.
3. Moinpour C.M., Feigl P., Metch B., Hayden K.A., Meyskens F.L., Crowley J. Quality of life end points in cancer clinical trials: reviews and recommendations. J Natl Cancer Inst. 81:1989;485-495.
4. Gotay C.C., Korn E.L., McCabe M.S., Moore T.D., Cheson B.D. Quality-of-life assessment in cancer treatment protocols: research issues in protocol development. J Natl Cancer Inst. 84:1992;575-579.
5. Nayfield S.G., Ganz P.A., Moinpour C.M., Cella D.F., Hailey B.J. Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials. Qual Life Res. 1:1992;203-210.
6. Machin D. Assessment of quality of life in clinical trials of the British Medical Research Council. J Natl Cancer Inst Monogr. 20:1996;97-102.
7. Rowland JH. Outcome assessment: cancer-specific quality-of-life measures - beyond the research setting. Educational Book, ASCO 33rd Annual Meeting, Denver; 1997. p. 342-9.
8. Ganz P.A. Quality of life and the patient with cancer: individual and policy implications. Cancer. 74:(Suppl 4):1994;1445-1452.
9. Sutherland H.J., Till J.E. Quality of life assessments and levels of decision making: differentiating objectives. Qual Life Res. 2:1993;297-303.
10. Spilker B. Introduction. Spilker B. Quality of life and pharmacoeconomics in clinical trials. 2nd ed:1996;1-10 Lippincott-Raven, Philadelphia.
11. Cella D., Tulsky D. Quality of life in cancer: definition, purpose, and method of measurement. Cancer Invest. 11:1993;327-336.
12. Aaronson N.K., Meyerowitz B.E., Bard M., Bloom J.R., Fawzy F.I., Feldstein M., et al. Quality of life research in oncology. Cancer. 67:(Suppl 3):1991;839-843.
13. Testa M.A., Simonson D.C. Assessment of quality-of-life outcomes. N Engl J Med. 334:1996;835-840.
14. Kurihara M., Shimizu H., Tsuboi K., Kobayashi K., Murakami M., Eguchi K., et al. Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy. Psychooncology. 8:1999;355-363.
15. Osoba D. Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol. 12:1994;608-616.
16. Gotay C.C. Trial-related quality of life: using quality-of-life assessment to distinguish among cancer therapies. J Natl Cancer Inst Monogr. 20:1996;1-6.
17. Schwartz C.E., Sprangers M.A.G. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 48:1999;1531-1548.
18. Sprangers M.A.G., Schwartz C.E. Integrating response shift into health-related quality-of-life research: a theoretical model. Soc Sci Med. 48:1999;1507-1515.
19. Ringdal G.I., Ringdal K. Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnosis. Qual Life Res. 2:1993;129-140.
20. Kobayashi K., Takeda F., Teramukai S., Gotoh I., Sakai H., Yoneda S., et al. A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. [see comments] Eur J Cancer. 34:1998;810-815.
21. Sutherland H.J., Lockwood G.A., Boyd N.F. Rating of the importance of quality of life variables: therapeutic implications for patients with metastatic breast cancer. J Clin Epidemiol. 43:1990;661-666.
22. Waldron D., O'Boyle C.A., Kearney M., Moriarty M., Carney D. Quality-of-life measurement in advanced cancer: assessing the individual. J Clin Oncol. 17:1999;3603-3611.
23. Matsumoto T., Ohashi Y., Morita S., Kobayashi K., Shibuya M., Yamaji Y., et al. QOL questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): validity and reliability in Japanese patients with advanced non-small-cell lung cancer. Qual Life Res. 11:2002;483-493.
24. Longford N.T. Random coefficient models. 1993;Oxford University Press, Oxford. 156-89.
25. Rutter M., Elashoff M. Analysis of longitudinal data: random coefficient regression modeling. Stat Med. 13:1994;1211-1231.
26. Stram D.O., Lee J.W. Variance components testing in the longitudinal mixed effects model. Biometrics. 50:1994;1171-1177.
27. Littell R., Milliken G., Stroup W., Wolfinger R. SAS system for mixed models. 1996;SAS Institute, Inc. Cary. p. 87-134.
28. Ganz PA. Psychosocial impact of different follow-up strategies in patients with common malignancies. Educational Book, ASCO 32nd annual meeting, Philadelphia; 1996. p. 331-3.
29. Bernhard B.J., Cella D.F., Coates A.S., Fallowfield L., Ganz P.A., Moinpour C.M., et al. Missing quality of life data in cancer clinical trials: serious problems and challenges. Stat Med. 17:1998;517-532.
30. Moinpour C.M., Lyons B., Grevstad P.K., Lovato L.C., Crowley J., Czaplicki K., et al. Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial. Qual Life Res. 11:2002;115-126.